Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil [Phase 3]
A Phase 3 clinical trial in Brazil comparing levocetirizine/pseudoephedrine versus Zina for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-10-31Clinical Trial Update: Allergic Rhinitis Combination Pharmacotherapy Efficacy Study [Phase 4]
Phase 4 clinical trial for allergic rhinitis combination pharmacotherapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-10-16Clinical Trial Update: Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis [Phase 2, Phase 3]
Phase 2/3 clinical trial of chlorpheniramine maleate nasal spray for allergic rhinitis and nasal congestion was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-10-31Clinical Trial Update: Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis [Phase 3]
A Phase 3 randomized trial comparing Cloratadd D (loratadine + pseudoephedrine sulfate) to Claritin D was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-08-05Clinical Trial Update: Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis [Phase 3]
Phase 3 trial of Magnólia nasal gel for allergic rhinitis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-11-04Clinical Trial Update: Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating mometasone nasal gel for persistent allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-11-04Clinical Trial Update: Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating mometasone nasal gel for persistent allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-10-09Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis [Phase 3]
A Phase 3 clinical trial comparing Noex 32µg to Budecort Aqua 32µg for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-10-09Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis [Phase 3]
Phase 3 non-inferiority study comparing Noex 50µg to Busonid 50µg for allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-23Clinical Trial Update: Diesel Exhaust Particles and Leukotriene Production
A clinical trial investigating the effects of diesel exhaust particles on leukotriene production in allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-25Clinical Trial Update: Preventing Tolerance to Oxymetazoline in Allergic Rhinitis [Phase 4]
A Phase 4 trial evaluating prevention of tolerance (tachyphylaxis) to oxymetazoline nasal decongestant in allergic rhinitis has been withdra…
-
CLINICAL_TRIALS withdrawal · 2014-01-09Clinical Trial Update: Phase 2 Study in Adults Sensitized to Short Ragweed [Phase 2]
A Phase 2 trial evaluating a treatment for allergic rhinitis in adults sensitized to short ragweed has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-07Clinical Trial Update: A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray [Phase 4]
This Phase 4 pilot trial comparing hypotonic and isotonic formulations of ciclesonide nasal spray for allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-03Clinical Trial Update: Topical Allstate and Nasal Allergen Challenge [Phase 3]
A Phase 3 trial evaluating topical Allstate and a nasal allergen challenge for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-12Clinical Trial Update: Azelastine Fluticasone Combination vs. Fluticasone [Phase 4]
A Phase 4 trial comparing an azelastine/fluticasone combination with fluticasone alone for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo [Phase 4]
A Phase 4 clinical trial evaluating onset of action of fluticasone furoate nasal spray and olopatadine nasal spray versus placebo for allerg…
-
CLINICAL_TRIALS withdrawal · 2011-08-29Clinical Trial Update: Comparison of Different Up-dosing Schedules With Osiris [Phase 2]
Phase 2 trial evaluating different up-dosing schedules of Osiris for allergic rhinitis has been terminated.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Allex (desloratadine) — Schering-Plough Europe
Desloratadine product Allex (Schering-Plough Europe) has been withdrawn from the market.